Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-04-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BEAUCHAMP (95250), Val-d'Oise
PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios
PHARMACIE DU MARCHE is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BEAUCHAMP (95250),
this company of category PME
shows in 2017 a revenue of 3.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MARCHE (SIREN 511498586)
Indicator
2023
2019
2017
2016
Revenue
N/C
N/C
3 322 211 €
3 364 373 €
Net income
241 482 €
163 778 €
213 705 €
211 986 €
EBITDA
N/C
N/C
304 047 €
353 822 €
Net margin
N/C
N/C
6.4%
6.3%
Revenue and income statement
In 2023, PHARMACIE DU MARCHE generates positive net income of 241 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 212 k€ -> 241 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
241 482 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 266%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
265.846%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
24.403%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2023
Debt ratio
141.379
112.325
77.216
265.846
Financial autonomy
37.178
42.102
50.401
24.403
Repayment capacity
9.607
10.751
None
None
Cash flow / Revenue
6.371%
5.258%
None%
None%
Sector positioning
Debt ratio
265.852023
2017
2019
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+30 pts over 3 years
In 2023, the debt ratio of PHARMACIE DU MARCHE (265.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
24.4%2023
2017
2019
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-33 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DU MARCHE (24.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
10.75 years2017
2017
Q1: 2.26 years
Med: 5.88 years
Q3: 10.41 years
Average
In 2017, the repayment capacity of PHARMACIE DU MARCHE (10.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 151.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
151.819
Liquidity indicators evolution PHARMACIE DU MARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2023
Liquidity ratio
158.853
166.443
144.249
151.819
Interest coverage
14.727
13.084
None
None
Sector positioning
Liquidity ratio
151.822023
2017
2019
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average-21 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DU MARCHE (151.82) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
13.08x2017
2017
Q1: 2.81x
Med: 8.18x
Q3: 15.34x
Good
In 2017, the interest coverage of PHARMACIE DU MARCHE (13.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 102 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 829 days. Excellent situation: suppliers finance 727 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
102 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
829 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU MARCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2023
Operating WCR
327 152 €
329 231 €
0 €
0 €
Inventory turnover (days)
28
30
0
0
Customer payment term (days)
6
6
0
102
Supplier payment term (days)
44
48
0
829
Positioning of PHARMACIE DU MARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DU MARCHE is estimated at
2 849 361 €
(range 1 732 832€ - 4 005 562€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1732k€2849k€4005k€
2 849 361 €Range: 1 732 832€ - 4 005 562€
NAF 5 année 2023
Valuation method used
Net Income Multiple
241 482 €
×
11.8x
=2 849 361 €
Range: 1 732 833€ - 4 005 562€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MARCHE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MARCHE
What is the revenue of PHARMACIE DU MARCHE ?
The revenue of PHARMACIE DU MARCHE in 2017 is 3.3 M€.
Is PHARMACIE DU MARCHE profitable?
Yes, PHARMACIE DU MARCHE generated a net profit of 241 k€ in 2023.
Where is the headquarters of PHARMACIE DU MARCHE ?
The headquarters of PHARMACIE DU MARCHE is located in BEAUCHAMP (95250), in the department Val-d'Oise.
Where to find the tax return of PHARMACIE DU MARCHE ?
The tax return of PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MARCHE operate?
PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart